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Watson is a fully developed suburb of some 30 years in
Canberra (the capital city of Australia). A plunge dip
using arsenical pesticides for tick control was operated
there between 1946 and 1960. Chemical investigations
revealed that many soil samples obtained from the study
area contained levels of arsenic exceeding the current
health-based investigation levels of 100 mg kg21 set by the
National Health and Medical Research Council in
Australia. For the speciation study, nine composite
samples of surface and sub-surface soils and a composite
sample of rocks were selected. ICP-MS analysis showed
that arsenic levels in these samples ranged from 32 to
1597 mg kg21. Chemical speciation of arsenic showed that
the arsenite (trivalent) components were 0.32–56% in the
soil and 44.8% in the rock composite samples. Using a rat
model, the absolute bioavailability of these contaminated
soils relative to As3+ or As5+ ranged from 1.02 to 9.87%
and 0.26 to 2.98%, respectively. An attempt was made to
develop a suitable leachate test as an index of
bioavailability. However, the results indicated that there
was no significant correlation between the bioavailability
and leachates using neutral pH water or 1 m HCl. Our
results indicate that speciation is highly significant for the
interpretation of bioavailability and risk assessment data;
the bioavailable fractions of arsenic in soils from Watson
are small and therefore the health impact upon the
environment and humans due to this element is limited.
Keywords: arsenic; metal speciation; bioavailability;
contaminated sites; risk assessment
Watson is a suburb in Canberra (the capital city of Australia),
approximately 6 km from the central business district. The study
site is located near the north-eastern corner of Watson, where a
plunge dip used arsenical pesticides for tick control between
1946 and 1960.
Chemical investigations revealed that many soil samples
obtained from the study site contained elevated levels of arsenic
and lead. The current National Health and Medical Research
Council (NHMRC) health-based investigation levels for arsenic
have been set at 100 mg kg21 in the soil. A thorough health risk
assessment including biological monitoring in residents has
been carried out. However, this paper concerns only the arsenic
contamination of the soil related to its speciation and absolute
bioavailability.
A gossan which can be encountered throughout the Austra-
lian Capital Territory (ACT) and the south-eastern region of
Australia has also been identified in the Watson study area.
Gossans are geological formations formed by the weathering
zones of sulfide mineralisation and are known sources of
arsenic and base metals. Therefore, the major source of arsenic
at Watson is likely to be naturally occurring within the rocks and
soil. There is also likely to be arsenic in the soil in some sections
of the study area as a result of earlier use as a sheep dip. For risk
assessment purposes, the potential harmful effects of arsenic
upon the environment, including the human health and
ecological risk, should be assessed in the same manner,
regardless whether the source of this element is natural or of
anthropogenic origin.
Labile metal species are considered to be more biologically
active than non-labile fractions. There are a number of tests for
availability of toxic materials from single components and from
mixtures,1,2,3 which are generally based on the assumption that
greater solubility enhances bioavailability. The metal distribu-
tion value can usually be obtained using sequential extraction
procedures, and several leaching schemes have been proposed
and widely adopted. However, such measures seldom give
anything other than qualitative guidance on the likely uptake by
organisms. Quantitative data should be obtained based on actual
measures of uptake of toxins, for example in animals or
humans.
The bioavailability of arsenic from contaminated land has
been assessed using small mammals4 including deer mice,
meadow voles, dogs5 and more typically guinea pigs or rabbits.6
The last work refers to the term ‘absolute bioavailability study’,
which involves orally dosing rabbits with the soil and keeping
them in metabolic cages with multiple samples of 24 h urine
collection over a period of days. The area under the plot of
arsenic excretion against time is then compared with that for
animals given an intravenous injection of the equivalent amount
of sodium arsenate to derive the absolute bioavailability.
Although researchers acknowledge the importance of obtaining
metal speciation data at contaminated sites, and understand that
the toxicology of an element is very much dependent on its
chemical species, there are few reports covering both metal
speciation and bioavailability data of contaminated soils in the
same study.
As part of an environmental health risk assessment in
Watson, we set out to measure the chemical speciation of
arsenic in the contaminated soil, to determine the solubility of
arsenic in aqueous solutions at pH 7.0 and 1.0 and to determine
the bioavailability of As by animal experimentation. The
correlation of solubility and bioavailability of As in these soils
was also examined.
Experimental
Soil treatment
Nine composite soil samples (C1–C9) of surface and sub-
surface soils and one rock composite sample (C10) from sites
† Presented at The Third International Symposium on Speciation of Elements in
Toxicology and in Environmental and Biological Sciences, Port Douglas, Australia,
September 15–19, 1997.
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containing a range of low to high levels of arsenic were
randomly selected. Most samples were obtained from resi-
dential properties, except C6, which was from a community
park reserve. C1–C5 were obtained in close proximity to the
plunge dip site. 
All soil samples had pre-treatment to ensure optimum
homogeneity for purposes of chemical analysis and animal
dosing, and were dried in a vacuum oven at 40 °C for at least 24
h, cooled, then ground to < 50 mm. Composite samples were
made up by weighing equal portions of individual soils and
mixing thoroughly in a screw-capped plastic jar. The composite
samples were stored in these jars at room temperature until
analysis or animal dosing.
Loose soil particles on the rocks were brushed off and washed
in water. The rocks were sonicated and rinsed in water until the
rinse water was clear, and given a final rinse in water purified
with a Milli-Q system (Millipore, Bedford, MA, USA) before
drying and grinding as above.
Arsenic speciation
The determination of the oxidation state the arsenic in the soil
was based on a recently published method7 with slight
modifications. Briefly, a 5 g sample of soil/rock ( < 50 mm
particle size) was extracted three times with 20 ml of 10 m
hydrochloric acid and the supernatant was filtered and diluted to
100 ml. For trivalent arsenic, a 10 ml aliquot of this arsenic
extract (AE) with 80 ml of 10 m hydrochloric acid was extracted
with chloroform (4 3 10 ml). The arsenic in the combined
chloroform extract was then back-extracted as AsCl3 into water
(3 3 15 ml) and diluted to 100 ml before ICP-MS or ETAAS
analysis.
For total arsenic, a 10 ml aliquot of AE and 10 ml of 50%
potassium iodide was heated in a water-bath for 30 min at 60 °C
for the conversion of pentavalent to trivalent arsenic. This
solution was cooled and diluted to 50 ml. An aliquot of this
solution, with 80 ml of 10 m hydrochloric acid, was extracted
and analysed in the same manner as for trivalent arsenic.
Animal dosing
Animal experimental protocols were approved by the UAEEC
(University of Queensland Animal Experimentation Ethics
Committee) and followed the NHMRC animal guidelines. Male
Wistar rats, 6 weeks old and weighing 170–190 g, were
obtained from the Central Animal Breeding House, University
of Queensland. All animals were kept in standard poly-
propylene laboratory animal cages to acclimatise for 48 h before
being placed in individual polycarbonate metabolic cages for 24
h urine collections prior to dosing. Soil samples suspended in
3–4 ml of water were administered orally by gavage to groups
of five rats without fasting, at a dose rate of 5.0 or 0.5 mg As
kg21 body mass, depending on the concentrations of arsenic in
the soils. The objective was to give the animal as much soil as
practically possible (1–2 g) at a given concentration in order to
evaluate potential toxic effects. For positive control, groups of
four rats were given the equivalent dose of arsenic by
intravenous injection of 0.5 mg As kg21 body mass in the form
of a solution of sodium arsenite or sodium arsenate. It is not
desirable to dose rats at 5.0 mg As kg21 body mass by the
intravenous route because it is a lethal dose. A negative control
group of rats was given 5 ml of water by oral gavage. The dosing
protocol is given in Table 1. All animals were given water and
commercial rat food diet through special feeders attached to the
metabolic cages. Urine samples (24 h) free from faecal
contamination were collected daily for 4 d after dosing. The
urine volume was recorded and the sample was divided into
aliquots in plastic containers and stored at 280 °C prior to
creatinine determination and elemental analysis. Rats were
anaesthetised with a mixture of carbon dioxide and oxygen
according to an approved UAEEC protocol8 and blood samples
were collected into lithium heparin tubes (Johns Professional
Products, Victoria, Australia) following exsanguination 4 d
after dosing for the elemental analysis. Faeces, liver and kidney
were also collected for analyses. The results will not be reported
here because tissue distribution data are less relevant to this
study. All organs of the experimental rats appeared normal at
necropsy.
Soil samples was digested in concentrated nitric acid in a
CEM MDS2000 microwave-assisted digestion system (CEM,
Matthews, NC, USA) based on the manufacturer’s recom-
mended procedures. The digest was diluted to contain 2% nitric
acid for ICP-MS measurement. Rat urine was diluted in 2%
nitric acid without digestion before analysis.
Water and 1 m HCl solubility (leachate)
A 2 g amount of soil / rock ( < 50 mm particle size) in 200 ml of
neutral Milli-Q-purified water 200 ml of 1 m HCl was extracted
in a conical flask by shaking (200 rpm) in an environmental
chamber at 25 ± 0.5 °C for 3 d. The extract was centrifuged and
filtered (0.45 mm filter membrane) prior to arsenic determina-
tion.
Results and discussion
Elemental analysis and speciation
As part of quality control/quality assurance (QC/QA) pro-
gramme, QC samples were analysed after every 6–10 speci-
mens in a run. The relative standard deviation (RSD) (n = 20)
of the ICP-MS results using a certified reference standard
solution (ICPMO 111-1; EM Science, Gibbstown, NJ, USA)
was 5.8%. An in-house rock digest gave an RSD of 3.2% (n =
6). When the certified standard was analysed using ICP-OES,
the corresponding RSD was 2.5% (n = 4). The analytical
results for the nine soils and one rock are given in Table 2, the
arsenic speciation results are given in Tables 3 and 4 and results
for water and 1 m HCl leachates of As in soils are given in Table
5. All results are the means of three readings. Random samples
were analysed and validated by independent operators using
ICP-MS, ETAAS and hydride generation AAS.
It has been suggested that arsenate (As5+) is the predominant
form of arsenic in aerated soil.9 When applied to soil, sodium
arsenite is oxidised to arsenate and remains in this form in
aerated soil, but when waterlogging and reducing conditions
prevail, some reconversion back to arsenite occurs. Arsenic
tends to become more tightly bound in soil with time after
application, and this depends on the availability of binding sites.
Table 1 Animal experimentation dosing regime for arsenic in soil and
control groups
Dosed Group
Dose rate/mg As kg21
body mass Route No.of rats
Experimental group—
C1 soil 0.5 Gavage 4
C2 soil 0.5 Gavage 5
C3 soil 0.5 Gavage 5
C4 soil 0.5 Gavage 5
C5 soil 0.5 Gavage 5
C6 soil 0.5 Gavage 5
C7 soil 5.0 Gavage 5
C8 soil 5.0 Gavage 5
C9 soil 5.0 Gavage 5
C10 rock 5.0 Gavage 5
Negative control group 0 Gavage 5
Positive control group—
Sodium arsenate 0.5 Intravenous 4
Sodium arsenite 0.5 Intravenous 4
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In the bound form, As is generally not readily leachable.
Leachate tests reported by McDougall10 conducted on As
contaminated soil obtained from a cattle tick dip site in NSW,
Australia, using distilled water for the extraction revealed that
for a soil containing 1000 mg kg21 of As, the concentration of
the As in the water was only 0.6 mg l21. This represents a 0.06%
solubility and implies that As remains tightly bound to the soil
component. It appears likely that little, if any, such As would be
biologically available. There are a number of tests for the
availability1–3 of toxic metals from contaminated soils, each
using dissolution in aqueous media at various pH values as a
measure of availability. However such measures are strictly
qualitative with respect to the likely uptake by organisms, and
quantitative measures must rely on actual measures of uptake by
animals or humans.11
It has been established that inorganic arsenite is more toxic
than arsenate.12 Arsenic can exist in the organic or inorganic
form, both of which are naturally occurring in the environment,
or may be the product of industrial activities. An important
distinction between inorganic and organic arsenic is that
exposure to the latter is not generally considered to result in
significant health risks.13 In addition, the concentrations of
dimethyl arsinic acid and monomethyl arsonic acid present in
the soil are usually not high enough to be considered a human
health risk factor; hence they were not measured in this study.
Although volatile arsine, the most toxic form of arsenic, is
sometimes formed in very small amounts under suitable
conditions, including microbial activity in the soil, it is
considered unlikely to be a significant risk factor. In this work,
only arsenite (trivalent arsenic) and total arsenic (arsenite +
arsenate) were measured in the soil and rock composite
samples. The arsenate portion (pentavalent arsenic) of the
sample was calculated by subtracting the arsenite from the total
arsenic concentration.
Bioavailability study
Absolute bioavailability (AB) is a definitive measurement of the
bioavailability of a chemical or a drug (arsenic in this case)
using an animal or human model. For the calculation of AB,
urinary arsenic measured at 0, 24, 48, 72 and 96 h intervals were
plotted. The area under each curve (AUC) was calculated using
a graphics software package (GraphPad Prism; GraphPad
Software, San Diego, CA, USA). The area under the curve for
animals dosed with intravenous injection (AUCi.v.) represented
an arbitrary value of 100%. The AUCoral, derived for animals
dosed by oral gavage, was then used to calculate the AB using
the following equation:
%AB (As) = 100AUC(oral)/AUC(i.v.)
Total arsenic excretion curves over a 96 h period for rats dosed
with soils, compared with the group of rats given a single
intravenous injection of sodium arsenite at 0.5 mg As3+ kg21
body mass or 0.5 mg As5+ kg21 body mass are illustrated in Fig.
1. The AB values of the various soils were calculated from Fig.
1. The results are given in Table 6.
Animal models4–6,14 are generally used to predict the
bioavailability of heavy metals. The absorption coefficient for
soluble salts of arsenic has been reported to range between 0.70
Table 2 Total concentrations of As in nine soils (C1–C9) and one rock
(C10) obtained from Watson
Soil/rock [As]/mg kg21 Solid/rock [As]/mg kg21
C1 55 C6 121
C2 32 C7 1597
C3 165 C8 867
C4 295 C9 1325
C5 67 C10 435
Table 3 Arsenic speciation results obtained for nine composite soils (C1–
C9) and one rock sample (C10)
Total arsenic/ Arsenite 
Sample mg kg21 (As3+) (%)
C1 55 0.33
C2 32 1.38
C3 165 1.01
C4 295 0.73
C5* 67 56
C6 121 0.32
C7 1597 0.53
C8 867 0.52
C9 1325 0.54
C10 435 44.8
* Arsenic speciation was subsequently determined in eight individual
soils of the composite C5 (see Table 4).
Table 4 Arsenic speciation of eight soils in the composite C5
Total arsenic/ Arsenite 
Soil sample mg kg21 As3+/mg kg21 (As3+) (%)
SS008-A 28.9 19.9 68.7
SS030-A 20.5 18.4 89.7
SS031-A 10.9 5.1 46.7
SS040-A 98.5 16.8 17.1
SS052-A 35.1 30.1 85.7
SS301-A 155.7 6.1 3.9
SS332-A 12.8 10.7 83.8
SS421-A 40.9 10.9 26.7
Mean 50.5 
s 35.9 
Table 5 Solubility (%) of As in the neutral pH water leachate and 1m HCl
leachate of nine soils (C1–C9) and one rock (C10) obtained from Watson
Sample Water leachate 1 m HCl leachate
C1 0.48 2.31
C2 < 0.13 2.00
C3 < 0.13 15.13
C4 0.23 22.00
C5 0.39 13.63
C6 < 0.13 1.99
C7 < 0.13 45.25
C8 0.24 31.88
C9 1.76 25.75
C10 < 0.13 12.00
Fig. 1 Bioavailability: urinary As excretion of rats dosed by gavage with
soils at a dose rate of 0.5 or 5.0 mg As kg21 compared with an i.v. injection
of sodium arsenate or sodium arsenite at 0.5 mg As kg21 body mass.
Analyst, May 1998, Vol. 123 891
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and 0.98.15 This absorption factor has often been assumed and
conservatively taken as 100% biologically available when the
worst case scenario is assumed in risk assessment. It has been
established that the rat is different from other mammals in that
it accumulates arsenic in the blood.16,17 In our experience, rats
accumulate arsenic in the blood up to 30–60 times more than
guinea pigs when given the same amount of sodium arsenate
and sodium arsenite, respectively. Therefore, rats could be used
as sensitive indicators for body absorption of arsenicals.11 The
rat model was chosen for the biological availability study for the
reason.18 A perfect animal model for studies on arsenic toxicity
and metabolism has not yet been identified.19 In this study, the
specific aim was to evaluate the bioavailability of arsenic
contaminated soil in relation to arsenate and arsenite, and rat can
therefore be used for this purpose.
The relevant arsenite and arsenate bioavailability data (AB)
were found to have no significant correlation with the water
leachate or the 1 m HCl leachate solutions of various soils. The
correlation coefficients (r2) were calculated to be 0.0395 and
0.0341 when compared with water leachate and 0.3026 and
0.3081 when compared with the acid leachate relative to the AB
values for arsenite and arsenate, respectively. These results
agreed with a previously reported18 low correlation (r2 = 0.54)
between acid leachates and bioavailabilities of As from an
anthropogenic origin. Our results suggest that one cannot use
merely the leachate data for the prediction of bioavailability of
As from these soils. The effect of elevated temperature (for
example, at 37 °C, body temperature) on the leachate concentra-
tion has not been investigated. However, it is believed that
elevated temperature would not have improved the correlation
significantly since the extraction regime was a continuous and
thorough leaching process over 3 days.
Eight out of ten soils tested in this study contained about 99%
of arsenic as arsenate (As5+), the exceptions being C5 and C10.
For practical purposes, one could calculate the AB using the
As5+ curve alone (Fig. 1), and the AB for these samples were
found to range from 0.55 to 2.98%, as shown in Table 6. The
AB’s of C10 were 0.26 and 1.02% relative to arsenate and
arsenite, respectively, and those of C5 were 2.98 and 9.58%,
respectively. The actual AB for C10 was calculated to be 0.64%
(average of 0.26 and 1.02%) and 6.28% (average of 2.98 and
9.58%) for C5, since the As3+ concentration was about 50% for
both samples (Table 5). The bioavailability of As relative to
arsenate in the soil from disused mining areas has been reported
as 11%20 and 24%14 in soil impacted by smelter activities;
arsenic speciation was not determined in these studies. These
bioavailability results were likely to be under-estimated if there
were significant concentrations of arsenite in the soil samples.
Our results illustrate the need for and importance of speciation
in order to obtain reliable bioavailability data. 
It is concluded that traditional risk assessment protocols
assuming 100% bioavailability will be over-conservative,
which in turn may result in unnecessary and expensive
remediation. The speciation of arsenic is highly relevant in
providing meaningful risk assessment data. Our results also
substantiate the need for site specific risk assessment. Since the
bioavailability of arsenic was relatively low in soils tested in
Watson, one could suggest that there would be very limited
health impact on the environment and humans in the study area
under the current residential usage of the land. This is consistent
with the biological monitoring results obtained from 31
residents, whose urinary arsenic levels were below the NHMRC
guideline value of 150 mg g21 creatinine. Notwithstanding that
the risk for the community in the suburb of Watson is limited,
the biological monitoring programme should be continued at
government level to safeguard the health status of people who
are living at this ‘contaminated site’.
The National Research Centre for Environmental Toxicology is
jointly funded by the National Health and Medical Research
Council, Queensland Health, Griffith University and the
University of Queensland.
References
1 Tessier, A., Campbell, P. G. C., and Bisson, M., Anal. Chem., 1979,
51, 844.
2 Pickering, W. F., CRC Crit. Rev. Anal. Chem. 1981, 12, 233.
3 Fo¨rstner, U., Anal. Chem., 1983, 316, 604.
4 Pascoe, G. A., Blanchet, R. J. and Linder, G., Arch. Environ. Contam.
Toxicol., 1994, 27(1), 44.
5 Groen, K., Vaessen, H. A. M. G., Kliest, J. J. G., Deboer, J. L. M.,
Vanooik, T., Timmerman, A., and Vlug, R.F., Environ. Health
Perspect., 1994, 102(2), 182.
6 Freeman, G. B., Johnson, J. D., Liao, S. C., Schoof, R. A., and
Bergstrom, P. D., in Proceedings of International Conference on
Arsenic Exposure and Health Effects, New Orleans, July 28–30,
1993, SEGH, Los Angeles, 1993, pp. 8–10.
7 Chappell, J., Chiswell, B., and Olszowy H., Talanta, 1995, 42(3),
323.
8 Fenwick, D. C., and Blackshaw, J. K., Lab. Anim.,. 1989, 23, 220.
9 Woolson, E. A., in Biological and Environmental Effects of Arsenic,
ed. Fowler, B. A., Elsevier, Amsterdam, 1983, pp. 51–139.
10 McDougall, K. W., in Proceedings of Risk Assessment Workshop, ed.
Powell, I., State Pollution Control Commission, Sydney, NSW, 1991,
pp. 1–24.
11 Ng, J. C., McDougall, K. W., Imray, P., Hertle, A. and Seawright,
A. A., in Proceedings (on Disks) of the 12th Australian Symposium on
Analytical Chemistry/3rd Environmental Chemistry Conference,
Perth, 26 September–1 October 1993, Royal Australian Chemical
Institute, Melbourne, 1993, 6pp.
12 Squibb, K. S., and Fowler, B. A., in Biological and Environmental
Effects of Arsenic, ed. Fowler, B. A., Elsevier, Amsterdam, 1983, pp.
233–269.
13 ATSDR (Agency for Toxic Substances and Disease Registry),
Toxicological Profile of Arsenic, US Public Health Service, Atlanta,
GA, 1993.
14 Freeman, G. B., Johnson, J. D., Killinger, J. M., Liao, S. C., Davis,
A. O., Ruby, M. V., Chaney, R. L., Lovre, S. C., and Bergstrom, P. D.,
Fundam. Appl. Toxicol., 1993, 21, 83.
15 Owen, B. A., Regul. Toxicol.. Pharmacol., 1990, 11, 237.
16 Odanaka, Y., Matan, O., and Goto, S., Bull. Environ. Contam.
Toxicol., 1980, 24, 452.
17 Chong, S., Dill, K., and McGown, E., J. Biochem. Toxicol.,1989,
4(1), 39.
18 Ng, J. C., and Moore, M. R., in The Health Risk Assessment and
Management of Contaminated Sites, ed. Langley, A., Markey, B., and
Hill, H., Public and Environmental Health Service, South Australian
Health Commission, South Australia Contaminated Sites Monograph
Series, No. 5, 1996, pp. 355–363.
19 Vahter, M., in Arsenic Exposure and Health, ed. Chappell, W. R.,
Abernathy, C. O., and Cothern, C. R., Science and Technology Letler,
Northwood, UK, 1994, pp. 171–179.
20 Davis, A., Ruby, M. V., and Bergstrom, P. D., Environ. Sci. Technol.,
1992, 26(3), 461.
Paper 7/07728I
Received October 27, 1997
Accepted March 6, 1998
Table 6 Absolute bioavailability (AB) relative to 0.5 mg kg21 i.v. of As5+ or
As3+
Sample Dose mg kg21 AB (cf. As5+)(%) AB (cf. As3+) (%)
C1 0.5 2.31 8.50
C2 0.5 1.27 4.31
C3 0.5 2.68 9.87
C4 0.5 1.44 5.56
C5 0.5 2.98 9.58
C6 0.5 2.46 7.25
C7 5.0 0.55 1.86
C8 5.0 0.59 1.18
C9 5.0 0.67 1.96
C10 5.0 0.26 1.02
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